Evaluating the Efficacy of a Screening Protocol for Severe Acute Respiratory Syndrome Coronavirus 2 Virus in Asymptomatic Preoperative/Preprocedural Patients at a Military Hospital.
Journal
Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R
Informations de publication
Date de publication:
11 Dec 2021
11 Dec 2021
Historique:
received:
03
09
2021
revised:
03
11
2021
accepted:
04
12
2021
entrez:
11
12
2021
pubmed:
12
12
2021
medline:
12
12
2021
Statut:
aheadofprint
Résumé
Facing the COVID-19 pandemic, many hospitals implemented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening protocols before aerosol-generating procedures (AGPs) in an effort to protect patients and health care workers. Given the limited prior evidence on the effectiveness of such protocols, we report the process improvement experience at a military treatment facility. We evaluated the outcomes of patients undergoing AGPs from March to September 2020, divided into three cohorts: a preprotocol (PP) cohort who did not receive screening, an early testing (ET) cohort representing the early months of the screening protocol, and a late testing (LT) cohort managed under adaptive modifications to the screening protocol. We recorded identifiable post-procedure COVID-19 diagnoses. The study was approved as a process improvement protocol and was determined not to meet criteria for human subject research through an institutional approval process. Across the three cohorts, 4520 procedures were performed: 422 PP, 1297 ET, and 2801 LT. Among 4098 procedures in the ET and LT cohorts, 12 asymptomatic patients tested positive for SARS-CoV-2 (0.29% positivity rate). One left the health system before completing the procedure and another proceeded urgently under COVID precautions, while 10 were rescheduled and completed at a later date; 7 were cleared using a test-based strategy, while 3 were cleared using a time-based strategy. Of 445 patients who had SARS-CoV-2 tests performed within 30 days following their procedures, three patients with negative preoperative tests had a positive test within 30 days, all in the LT cohort but had evidence of acquiring the infection after the procedure or had a false-positive test. Our strategy of preprocedural SARS-CoV-2 testing successfully identified asymptomatic infected patients before surgery. Care was delayed for most of these patients without apparent detriment. Adaptation to a time-based strategy for clearance might reduce such delays, but other considerations may still influence how soon procedures should be completed after a positive test.
Identifiants
pubmed: 34894142
pii: 6459425
doi: 10.1093/milmed/usab522
pmc: PMC9383072
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Références
Int J Infect Dis. 2020 Sep;98:180-186
pubmed: 32562846
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
J Am Coll Surg. 2020 Dec;231(6):789-790
pubmed: 32951984
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
World J Surg. 2020 Aug;44(8):2477-2481
pubmed: 32418028
Auris Nasus Larynx. 2020 Aug;47(4):687-691
pubmed: 32425317
Am J Surg. 2021 Apr;221(4):770-771
pubmed: 32981653
J Infect Prev. 2021 Jan;22(1):7-11
pubmed: 33841556
Pol Przegl Chir. 2020 Apr 15;92(2):48-59
pubmed: 32312919
Otolaryngol Head Neck Surg. 2020 Aug;163(2):265-270
pubmed: 32452746
Arthrosc Sports Med Rehabil. 2020 Apr 27;2(3):e177-e183
pubmed: 32342047
Surg Today. 2020 Sep;50(9):1107-1112
pubmed: 32700005
Surgery. 2020 Aug;168(2):209-211
pubmed: 32425247
J Visc Surg. 2020 Jun;157(3 Suppl 1):S69-S70
pubmed: 32381427
Anaesthesia. 2021 Jun;76(6):748-758
pubmed: 33690889
J Exp Orthop. 2020 May 13;7(1):28
pubmed: 32405872